Israel Englander Immuneering Corp Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Immuneering Corp stock. As of the latest transaction made, Millennium Management LLC holds 23,065 shares of IMRX stock, worth $34,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,065
Previous 102,936
77.59%
Holding current value
$34,828
Previous $226,000
84.51%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMRX
# of Institutions
37Shares Held
4.78MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.6 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0808KShares$1.22 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD659KShares$995,1030.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$805,3790.0% of portfolio
-
Morgan Stanley New York, NY467KShares$705,5110.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $39.9M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...